Table 1. Description of studies with a reported incidence of POSS after ARCR.
Number | Author (year) | Level of evidence | Type of study | Type of tear | Number of patients | Cases of POSS | Incidence of POSS |
1 | Shin (2018) [2] | II | Randomized controlled trial | Partial | 48 | 5 | 10.4% |
2 | Smolen (2020) [10] | IV | Prospective cohort | All tears | 50 | 6 | 12% |
3 | Cole (2007) [11] | IV | Prospective cohort | Full thickness | 47 | 0 | 0% |
4 | Ranalletta (2016) [12] | IV | Prospective cohort | Partial | 80 | 5 | 6.3% |
5 | Youm (2005) [13] | IV | Retrospective cohort | All tears | 42 | 2 | 4.8% |
6 | Felsch (2021) [14] | IV | Retrospective cohort | Partial | 350 | 39 | 11.1% |
Felsch (2021) [14] | IV | Retrospective cohort | Full thickness | 1,311 | 88 | 6.7% | |
7 | Teratani (2019) [15] | III | Retrospective cohort | All tears | 213 | 17 | 8% |
8 | Toussaint (2011) [16] | IV | Retrospective cohort | All tears | 154 | 17 | 11% |
9 | Sheps (2019) [17] | I | Randomized controlled trial | Full thickness | 206 | 3 | 1.5% |
10 | Guity (2021) [18] | IV | Retrospective cohort | All tears | 335 | 121 | 36.1% |
11 | Miyazaki (2009) [19] | IV | Retrospective cohort | All tears | 61 | 2 | 3.3% |
12 | Vap (2017) [20] | IV | Retrospective cohort | Partial | 20 | 0 | 0% |
13 | Tan (2020) [21] | IV | Retrospective cohort | All tears | 290 | 32 | 11% |
14 | Cho (2022) [6] | IV | Retrospective cohort | All tears | 274 | 39 | 14.2% |
15 | Huberty (2009) [8] | IV | Retrospective cohort | All tears | 489 | 24 | 4.9% |
16 | Yeazell (2022) [22] | III | Prospective cohort | Partial | 64 | 9 | 14.1% |
17 | Wang (2022) [23] | III | Retrospective cohort | All tears | 3,266 | 36 | 1.1% |
18 | Posada (2000) [24] | IV | Prospective cohort | Full thickness | 60 | 2 | 3.3% |
19 | Jenssen (2018) [25] | I | Prospective cohort | Full thickness | 118 | 2 | 1.7% |
20 | Audigé (2021) [4] | III | Retrospective cohort | All tears | 1,330 | 112 | 8.4% |
21 | Schneider (2021) [26] | III | Retrospective cohort | All tears | 126 | 9 | 7.1% |
22 | Blonna (2017) [7] | II | Prospective cohort | All tears | 31 | 7 | 22.6% |
23 | Shin (2012) [27] | II | Prospective control | Full thickness | 120 | 1 | 0.8% |
24 | Cucchi (2020) [28] | IV | Prospective cohort | All tears | 237 | 19 | 8% |
25 | Takahashi (2022) [29] | IV | Retrospective cohort | All tears | 51 | 0 | 0% |